Research and Development Expense (TTM) Chart

Historical Research and Development Expense (TTM) Data

View and export this data back to 1999. Start Trial.
Date Value
December 31, 2024 0.749M
September 30, 2024 0.855M
June 30, 2024 0.958M
March 31, 2024 1.055M
December 31, 2023 1.144M
September 30, 2023 1.182M
June 30, 2023 1.235M
March 31, 2023 1.306M
December 31, 2022 1.326M
September 30, 2022 1.316M
June 30, 2022 1.232M
March 31, 2022 1.168M
December 31, 2021 1.13M
September 30, 2021 1.116M
June 30, 2021 1.177M
March 31, 2021 1.229M
December 31, 2020 1.28M
September 30, 2020 1.335M
June 30, 2020 1.423M
March 31, 2020 1.478M
December 31, 2019 1.567M
September 30, 2019 1.675M
June 30, 2019 1.654M
March 31, 2019 1.612M
December 31, 2018 1.551M
Date Value
September 30, 2018 1.441M
June 30, 2018 1.422M
March 31, 2018 1.385M
December 31, 2017 1.356M
September 30, 2017 1.36M
June 30, 2017 1.355M
March 31, 2017 1.384M
December 31, 2016 1.415M
September 30, 2016 1.406M
June 30, 2016 1.450M
March 31, 2016 1.537M
December 31, 2015 1.632M
September 30, 2015 1.647M
June 30, 2015 1.619M
March 31, 2015 1.459M
December 31, 2014 1.348M
September 30, 2014 1.253M
June 30, 2014 1.093M
March 31, 2014 1.005M
December 31, 2013 0.8251M
September 30, 2013 0.7045M
June 30, 2013 0.7983M
March 31, 2013 0.8222M
December 31, 2012 0.8255M
September 30, 2012 0.8867M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Quest Diagnostics, Inc. --
Labcorp Holdings, Inc. --
OPKO Health, Inc. 125.22M
NeoGenomics, Inc. 38.17M
First Choice Healthcare Solutions, Inc. --